Christina Annunziata, MD, PhD of National Institutes of Health discusses how to take a drug from phase 1 to phase 3. She explains further on how the drug needs to be targeted to the patient with the right marker. This was recorded at the 2017 Society of Gynecologic Oncology (SGO)s Annual Meeting on Womens Cancer® in National Harbor, MD.
How to Take a Drug Directly from Phase 1 to Phase 3
